慢性血液透析患者疾病激活与控制的观察研究

IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Nefrologia Pub Date : 2024-05-01 DOI:10.1016/j.nefro.2023.05.009
Sara Ramírez-Sánchez , María Jesús Soriano-Munuera , Elena Lucía Gras-Colomer , Alicia Cana-Poyatos , Teresa García-Martínez , Rafael Ortiz-Ramón , Sara Linares-Aguayo , Alicia García-Testal
{"title":"慢性血液透析患者疾病激活与控制的观察研究","authors":"Sara Ramírez-Sánchez ,&nbsp;María Jesús Soriano-Munuera ,&nbsp;Elena Lucía Gras-Colomer ,&nbsp;Alicia Cana-Poyatos ,&nbsp;Teresa García-Martínez ,&nbsp;Rafael Ortiz-Ramón ,&nbsp;Sara Linares-Aguayo ,&nbsp;Alicia García-Testal","doi":"10.1016/j.nefro.2023.05.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><p>Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.</p></div><div><h3>Results</h3><p>The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (<em>P</em> = .003), blood flow (<em>P</em> = .024), and interdialytic gain of patients (<em>P</em> = .008).</p></div><div><h3>Conclusions</h3><p>Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.</p></div>","PeriodicalId":18997,"journal":{"name":"Nefrologia","volume":"44 3","pages":"Pages 423-430"},"PeriodicalIF":2.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0211699523000784/pdfft?md5=839865158b5e701caffe892fd17553f1&pid=1-s2.0-S0211699523000784-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Activación y control de enfermedad de pacientes en tratamiento crónico con hemodiálisis: un estudio observacional\",\"authors\":\"Sara Ramírez-Sánchez ,&nbsp;María Jesús Soriano-Munuera ,&nbsp;Elena Lucía Gras-Colomer ,&nbsp;Alicia Cana-Poyatos ,&nbsp;Teresa García-Martínez ,&nbsp;Rafael Ortiz-Ramón ,&nbsp;Sara Linares-Aguayo ,&nbsp;Alicia García-Testal\",\"doi\":\"10.1016/j.nefro.2023.05.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objective</h3><p>Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.</p></div><div><h3>Results</h3><p>The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (<em>P</em> = .003), blood flow (<em>P</em> = .024), and interdialytic gain of patients (<em>P</em> = .008).</p></div><div><h3>Conclusions</h3><p>Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.</p></div>\",\"PeriodicalId\":18997,\"journal\":{\"name\":\"Nefrologia\",\"volume\":\"44 3\",\"pages\":\"Pages 423-430\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0211699523000784/pdfft?md5=839865158b5e701caffe892fd17553f1&pid=1-s2.0-S0211699523000784-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nefrologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0211699523000784\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nefrologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0211699523000784","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的患者激活是一个概念,指的是患者管理自身健康和医疗护理的意愿。为了对其进行评估,已经开发并验证了患者激活度量表(PAM)。一些研究报告称,慢性病患者的积极性较低。然而,有关血液透析患者积极性的信息却很少。本研究旨在描述在血液透析室接受慢性治疗的患者的激活水平及其与疾病控制参数的关系。共纳入 96 名患者。用 PAM-13 问卷测量了激活度。研究了其与描述性变量(年龄、性别、合并症、学习、生活习惯)和疾病控制变量(血管通路、血流量、钾血症、磷血症、透析间期增益)之间的关系。结果 PAM-13 评分的平均值(标清)为 63.19(15.21)分。活化与血管通路(P = .003)、血流量(P = .024)和患者的透析间期收益(P = .008)明显相关。慢性血液透析患者的激活率较低,激活率较高与动静脉瘘、较高的血流量和较低的透析间期增益有关。未来的研究需要证实并应用我们的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Activación y control de enfermedad de pacientes en tratamiento crónico con hemodiálisis: un estudio observacional

Background and objective

Patient activation is a concept that refers to the willingness to manage one's health and medical care. To assess it, a patient activation measure (PAM) has been developed and validated. Several studies report low activation in patients with chronic diseases. However, information on activation in hemodialysis patients is scarce. The aim of the present study is to describe the activation level of patients on chronic treatment in an HD unit and its relationship with disease control parameters.

Materials and methods

Cross-sectional observational study in patients with advanced chronic kidney disease on chronic HD treatment. Ninety-six patients were included. Activation was measured with the PAM-13 questionnaire. Its relationship with descriptive variables (age, sex, comorbidity, studies, habitat) and disease control variables (vascular access, blood flow, potassaemia, phosphataemia, interdialytic gain) was studied. For this purpose, Spearman's correlation test, multiple linear regression model and logistic model were used as statistical methods.

Results

The mean (SD) PAM-13 score was 63.19 (15.21). Activation was significantly associated with vascular access (P = .003), blood flow (P = .024), and interdialytic gain of patients (P = .008).

Conclusions

Activation in patients on chronic hemodialysis treatment is low. Higher activation is related having an arteriovenous fistula, higher blood flow and lower interdialytic gain. Future studies are needed to confirm and apply our results.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nefrologia
Nefrologia 医学-泌尿学与肾脏学
CiteScore
3.40
自引率
7.70%
发文量
148
审稿时长
47 days
期刊介绍: Nefrología is the official publication of the Spanish Society of Nephrology. The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. It is governed by the peer review system and all original papers are subject to internal assessment and external reviews. The journal accepts submissions of articles in English and in Spanish languages.
期刊最新文献
Uso de los agonistas del receptor del péptido similar al glucagón tipo 1 en pacientes trasplantados renales La gota preclínica es frecuente en el paciente con enfermedad renal crónica estadio 3-5. Relevancia de la ecografía articular Renata, mi nefróloga, ¿puede la literatura infantil actuar como instrumento de sensibilización y prevención de la enfermedad renal? Proyección de la carga clínica y económica de la enfermedad renal crónica entre 2022 y 2027 en España: resultados del proyecto Inside CKD Aféresis terapéutica en gestante con hipercolesterolemia familiar heterocigota
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1